Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
9.99
+0.14 (1.42%)
May 27, 2025, 3:32 PM - Market open
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $859.61 million as of May 27, 2025. Its market cap has decreased by -54.80% in one year.
Market Cap
859.61M
Enterprise Value
691.51M
1-Year Change
-54.80%
Ranking
Category
Stock Price
$9.99
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $859.61M, an increase of 312.09%. That is a compound annual growth rate of 16.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 847.60M | -24.88% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 298.78B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 221.01B |
| AstraZeneca | 218.42B |